Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials
- PMID: 30446816
- DOI: 10.1007/s00431-018-3282-z
Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials
Abstract
Therapy-related side effects and severe antimicrobial resistance still remain an obstacle to Helicobacter pylori eradication. This meta-analysis aimed to investigate the efficacy of Lactobacillus-supplemented triple therapy on H. pylori eradication rates and therapy-related side effects in children. Five studies involving 484 pediatric patients were included in our analysis. The pooled relative risk (RR) for eradication rates in the Lactobacillus group versus the control group was 1.19 [95% confidence interval (CI) 1.07-1.33]. In subgroup analyses based on dose and duration of Lactobacillus supplementation, the pooled RRs for eradication rates were 1.36 (95% CI 1.15-1.60) in the high-dose group, 1.08 (95% CI 0.86-1.35) in the low-dose group, 1.24 (95% CI 1.06-1.46) in the long-term group, and 1.17 (95% CI 0.96-1.44) in the short-term group. With respect to side effects, Lactobacillus supplementation significantly reduced the incidence of diarrhea (RR = 0.30, 95% CI 0.10-0.85).Conclusions: Lactobacillus, as an adjunct to triple therapy, can increase H. pylori eradication rates as well as reduce the incidence of therapy-related diarrhea in children. And a higher dose and a longer duration of supplementation may conduce to the positive impact of Lactobacillus on H. pylori eradication. What is Known: • Probiotics-supplemented triple therapy may be beneficial in improving H. pylori eradication rates and reducing therapy-related side effects in children. However, not all probiotics are beneficial to H. pylori eradication and the pooled outcomes based on different probiotics may be erroneously extrapolated to other ineffective strains. What is New: • Lactobacillus, as an adjunct to triple therapy, can increase H. pylori eradication rates as well as reduce the incidence of therapy-related diarrhea in children.
Keywords: Children; H. pylori; Lactobacillus; Meta-analysis; Triple therapy.
Similar articles
-
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016. PLoS One. 2016. PMID: 27723762 Free PMC article. Review.
-
Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children.Eur J Pediatr. 2014 Feb;173(2):153-61. doi: 10.1007/s00431-013-2220-3. Epub 2013 Dec 10. Eur J Pediatr. 2014. PMID: 24323343
-
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children.J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):431-6. doi: 10.1097/mpg.0b013e318182e716. J Pediatr Gastroenterol Nutr. 2009. PMID: 19330931 Clinical Trial.
-
Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy.J Clin Gastroenterol. 2013 Jan;47(1):25-32. doi: 10.1097/MCG.0b013e318266f6cf. J Clin Gastroenterol. 2013. PMID: 23090045
-
Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.Helicobacter. 2024 Nov-Dec;29(6):e70006. doi: 10.1111/hel.70006. Helicobacter. 2024. PMID: 39722187
Cited by
-
Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection.Genome Biol. 2020 Apr 28;21(1):99. doi: 10.1186/s13059-020-02007-1. Genome Biol. 2020. PMID: 32345342 Free PMC article.
-
The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.Nutrients. 2024 Oct 30;16(21):3706. doi: 10.3390/nu16213706. Nutrients. 2024. PMID: 39519539 Free PMC article. Review.
-
Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children.Pediatr Gastroenterol Hepatol Nutr. 2024 Jan;27(1):1-14. doi: 10.5223/pghn.2024.27.1.1. Epub 2024 Jan 9. Pediatr Gastroenterol Hepatol Nutr. 2024. PMID: 38249642 Free PMC article. Review.
-
Anticandidal Activities by Lactobacillus Species: An Update on Mechanisms of Action.Front Oral Health. 2021 Jul 16;2:689382. doi: 10.3389/froh.2021.689382. eCollection 2021. Front Oral Health. 2021. PMID: 35048033 Free PMC article. Review.
-
Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents.Arch Microbiol. 2023 Aug 7;205(9):301. doi: 10.1007/s00203-023-03639-0. Arch Microbiol. 2023. PMID: 37550555 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical